Article / Natural Product ResearchArticle / Natural Product ResearchArticle / Natural Product ResearchArticle / Natural Product Research
  • RESEARCH CENTERS
  • CORE FACILITIES
    • Advanced Microscopy
    • Cell Culture
    • Molecular Cell Biology
    • Proteomics
    • Drug Discovery
    • Bioinformatics
    • Biomaterials
    • Electrophysiology and Behavior
    • Cognitive Neuroscience
    • Animal House
  • PEOPLE
    • Administration
    • Group Leader
    • Transition Scientist
    • Early Career Researchers
    • Students
  • EVENTS
    • Event Calendar
    • Critical Mind
    • SABITALKS
    • InFocus
    • CROSSTALKS
    • MODAS WS
    • SABITA Podcast
    • Social
  • ABOUT US
    • Our Mission
    • Gender Equality Policy
  • RESEARCH CENTERS
  • CORE FACILITIES
    • Advanced Microscopy
    • Cell Culture
    • Molecular Cell Biology
    • Proteomics
    • Drug Discovery
    • Bioinformatics
    • Biomaterials
    • Electrophysiology and Behavior
    • Cognitive Neuroscience
    • Animal House
  • PEOPLE
    • Administration
    • Group Leader
    • Transition Scientist
    • Early Career Researchers
    • Students
  • EVENTS
    • Event Calendar
    • Critical Mind
    • SABITALKS
    • InFocus
    • CROSSTALKS
    • MODAS WS
    • SABITA Podcast
    • Social
  • ABOUT US
    • Our Mission
    • Gender Equality Policy

Article / Natural Product Research

Linarin inhibits survival and metastasis in triple-negative breast cancer cell line MDA-MB-231 by downregulating NF-κB p-p65/MMP-9, upregulating Bax, and enhancing Caspase 3/7 expression

Talat Yasin Acar, Muhammet Volkan Bulbul, Emre Vatandaslar, Aysenur Kurt, Semiha Mervenur Kalender, Ilknur Keskin & Bircan Kolbasi

Abstract

Triple Negative Breast Cancer (TNBC) is an aggressive type of breast cancer that is responsible for most of the cancer related deaths in women. Traditional two-dimensional (2D) cell cultures are insufficient to mimic the complex tumour environment, so three-dimensional (3D) spheroid cultures are used to provide a more accurate model. Our study explores the anticancer and antimetastatic effects of linarin on TNBC cell line MDA-MB-231 cells. We conducted experiments using both 2D and 3D cultured cells. Linarin treatment reduced cell viability (2D IC50:120.8 µM ***p < 0.001, 3D IC50: 1949 µM ****p < 0.0001 respectively) and migration (***p < 0.001, ****p < 0.0001), increased apoptosis, and upregulated Bax and Caspase3/7 protein levels (****p < 0.0001). It also reduced p-p65 and MMP-9 protein expression levels (****p < 0.0001), suggesting possible suppression of survival and metastatic pathways. Linarin also led to a loss of spheroid compactness suggesting interference with its cancer-promoting activities. These findings suggest that linarin could be a promising therapeutic option for TNBC.

 
Click here for article
Share

SOCIAL MEDIA

SHORTCUT LINKS

 

  • Contact
  • Corporate Identity
  • Referrence Guide
  • Request Forms
  • Sabita 360°
  • Sabita Society
  • Social

OUR MISSION

Translation of Scientific Findings From Bench to Bedside

  • Read More
  • © 2025 Medipol University | SABITA Research Institute for Health Sciences and Technologies
    [contact-form-7 id="50" title="Contact form 1"]